Phase 1 Study of the Litx™ BPH System in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)

NCT00709488 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Benign Prostatic Hyperplasia
Lower Urinary Tract Symptoms

Interventions

DRUG: Talaporfin sodium
PROCEDURE: Placement of device in prostate urethra
DEVICE: Transurethral illumination with light emitting diodes (Litx™ BPH Device)

Sponsor

Light Sciences Oncology